Dedic Nina, Chen Alon, Deussing Jan M
Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Kraepelinstr, 2-10, 80804 Munich. Germany.
Curr Mol Pharmacol. 2018;11(1):4-31. doi: 10.2174/1874467210666170302104053.
Dysregulated stress neurocircuits, caused by genetic and/or environmental changes, underlie the development of many neuropsychiatric disorders. Corticotropin-releasing factor (CRF) is the major physiological activator of the hypothalamic-pituitary-adrenal (HPA) axis and consequently a primary regulator of the mammalian stress response. Together with its three family members, urocortins (UCNs) 1, 2, and 3, CRF integrates the neuroendocrine, autonomic, metabolic and behavioral responses to stress by activating its cognate receptors CRFR1 and CRFR2.
Here we review the past and current state of the CRF/CRFR field, ranging from pharmacological studies to genetic mouse models and virus-mediated manipulations.
Although it is well established that CRF/CRFR1 signaling mediates aversive responses, including anxiety and depression-like behaviors, a number of recent studies have challenged this viewpoint by revealing anxiolytic and appetitive properties of specific CRF/CRFR1 circuits. In contrast, the UCN/CRFR2 system is less well understood and may possibly also exert divergent functions on physiology and behavior depending on the brain region, underlying circuit, and/or experienced stress conditions.
A plethora of available genetic tools, including conventional and conditional mouse mutants targeting CRF system components, has greatly advanced our understanding about the endogenous mechanisms underlying HPA system regulation and CRF/UCN-related neuronal circuits involved in stress-related behaviors. Yet, the detailed pathways and molecular mechanisms by which the CRF/UCN-system translates negative or positive stimuli into the final, integrated biological response are not completely understood. The utilization of future complementary methodologies, such as cell-type specific Cre-driver lines, viral and optogenetic tools will help to further dissect the function of genetically defined CRF/UCN neurocircuits in the context of adaptive and maladaptive stress responses.
由遗传和/或环境变化引起的应激神经回路失调是许多神经精神疾病发生的基础。促肾上腺皮质激素释放因子(CRF)是下丘脑-垂体-肾上腺(HPA)轴的主要生理激活剂,因此是哺乳动物应激反应的主要调节因子。CRF与其三个家族成员,即尿皮质素(UCNs)1、2和3一起,通过激活其同源受体CRFR1和CRFR2,整合对压力的神经内分泌、自主神经、代谢和行为反应。
本文综述CRF/CRFR领域的过去和现状,范围从药理学研究到基因小鼠模型和病毒介导的操作。
尽管CRF/CRFR1信号传导介导厌恶反应(包括焦虑和抑郁样行为)这一点已得到充分证实,但最近的一些研究通过揭示特定CRF/CRFR1回路的抗焦虑和食欲特性对这一观点提出了挑战。相比之下,UCN/CRFR2系统的了解较少,并且根据脑区、潜在回路和/或经历的应激条件,可能对生理和行为也发挥不同的功能。
大量可用的遗传工具,包括针对CRF系统组件的传统和条件性小鼠突变体,极大地推进了我们对HPA系统调节的内源性机制以及参与应激相关行为的CRF/UCN相关神经回路的理解。然而,CRF/UCN系统将负面或正面刺激转化为最终综合生物学反应的详细途径和分子机制尚未完全明了。未来互补方法的应用,如细胞类型特异性Cre驱动系、病毒和光遗传学工具,将有助于在适应性和适应不良应激反应的背景下进一步剖析基因定义的CRF/UCN神经回路的功能。